Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 18;12(10):e11019.
doi: 10.7759/cureus.11019.

Correlation of Fasting Lipid Profile in Patients With Chronic Liver Disease: A Descriptive Cross-Sectional Study in Tertiary Care Hospital

Affiliations

Correlation of Fasting Lipid Profile in Patients With Chronic Liver Disease: A Descriptive Cross-Sectional Study in Tertiary Care Hospital

Abubakar Tauseef et al. Cureus. .

Abstract

Introduction: Chronic liver disease (CLD) is a term used to describe a wide spectrum of disorders, including idiopathic, infectious, genetic, drug-induced, toxin-induced, and autoimmune disorders. The common consequence of chronic damage to the liver is cirrhosis. Cirrhotic patients are further classified by their severity based on the Child-Pugh scoring system. Currently, Child-Pugh scoring consists of ascites, hepatic encephalopathy (HE), prothrombin time, serum albumin level, and total bilirubin level. Lipid panel in CLD is a great marker in determining the severity of CLD. Method and methodology: It was a descriptive cross-sectional study conducted at a tertiary care hospital. A sample size of 122 was calculated by using a RaoSoft Digital Sample Size Calculator (RaoSoft, Inc., Seattle, WA) in which we used 5% as a margin of error, 95% as confidence interval (CI), 178 as population size, and response distribution as 50%. Non-complicated CLD patients having age in between 15 and 80 years with no cirrhotic complications including HE, spontaneous bacterial peritonitis, hepato-pumonary, or hepato-renal syndrome were included in our study; the rest of the CLD patients were excluded from our study.

Results: The mean age of the study population was 47.09 ± 12.30 years with more than half of the patients lying among the age group 25-50 years. The study population included 76% of males (n=93) and 24% of females (n=29), with a mean age of females higher than the males. Diabetes mellitus (58.19%) was the most frequent comorbidity associated with CLD in subjects included in our study. Parameters of lipid panel were decreased exponentially as the severity of CLD increases from Child score A to C. Total cholesterol, low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), high-density lipoprotein (HDL), and triglyceride (TG) level decreased as the severity increases in our study. The mean model for end-stage liver disease (MELD) score increased as per hypothesized as the severity increases from Child score A to Child score C, respectively.

Conclusion: Our study concluded that as the severity of CLD increases from Child class A to Child class C, the lipid panel profile decreases exponentially which proved the idea that had been hypothesized at the beginning of our study.

Keywords: chronic liver disease; correlation; descriptive; lipid panel; tertiary care.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

Cited by

References

    1. Dyslipidemia and hyperinsulinemia in children and adolescents with chronic liver disease: relation to disease severity. El-Kabbany ZA, Hamza RT, Ibrahim SA, Mahmoud NH. Int J Adolesc Med Health. 2014;26:195–201. - PubMed
    1. Fibrogenesis in alcoholic liver disease. Fujii H, Kawada N. World J Gastroenterol. 2014;20:8048–8054. - PMC - PubMed
    1. Epidemiology and clinical evolution of liver cirrhosis in Singapore. Chang PE, Wong GW, Li JW, Lui HF, Chow WC, Tan CK. https://pubmed.ncbi.nlm.nih.gov/26292950/ Ann Acad Med Singap. 2015;44:218–225. - PubMed
    1. Efficacy of a chronic disease management model for patients with chronic liver failure. Wigg AJ, McCormick R, Wundke R, Woodman RJ. Clin Gastroenterol Hepatol. 2013;11:850–858. - PubMed
    1. Burden of liver diseases in the world. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. J Hepatol. 2019;70:151–171. - PubMed

LinkOut - more resources